Literature DB >> 1601585

Technology assessment in a user perspective--experiences with drug technology.

E H Hansen1.   

Abstract

Drugs have a central place among medical technologies, and medical technology assessment can learn from the established regulation of drug technology. This article outlines how users' experiences are not part of the basis on which decisions are made today, although this knowledge is imperative for identifying the problems that are not uncovered or foreseen by today's drug assessments. Further, users' interests might not be part of assessments that are based on the controlled clinical trial. A framework for drug technology assessments based on a user perspective is suggested.

Mesh:

Year:  1992        PMID: 1601585     DOI: 10.1017/s0266462300008011

Source DB:  PubMed          Journal:  Int J Technol Assess Health Care        ISSN: 0266-4623            Impact factor:   2.188


  8 in total

1.  Knowledge creation about ADRs--turning the perspective from the rear mirror to the projector?

Authors:  Lise Aagaard; Birthe Soendergaard; Doris I Stenver; Ebba Holme Hansen
Journal:  Br J Clin Pharmacol       Date:  2007-10-24       Impact factor: 4.335

2.  Adverse drug reactions in the paediatric population in Denmark: a retrospective analysis of reports made to the Danish Medicines Agency from 1998 to 2007.

Authors:  Lise Aagaard; Camilla Blicher Weber; Ebba Holme Hansen
Journal:  Drug Saf       Date:  2010-04-01       Impact factor: 5.606

3.  Global patterns of adverse drug reactions over a decade: analyses of spontaneous reports to VigiBase™.

Authors:  Lise Aagaard; Johanna Strandell; Lars Melskens; Paw S G Petersen; Ebba Holme Hansen
Journal:  Drug Saf       Date:  2012-12-01       Impact factor: 5.606

4.  Adverse drug reactions from psychotropic medicines in the paediatric population: analysis of reports to the Danish Medicines Agency over a decade.

Authors:  Lise Aagaard; Ebba H Hansen
Journal:  BMC Res Notes       Date:  2010-06-23

5.  The occurrence of adverse drug reactions reported for attention deficit hyperactivity disorder (ADHD) medications in the pediatric population: a qualitative review of empirical studies.

Authors:  Lise Aagaard; Ebba Holme Hansen
Journal:  Neuropsychiatr Dis Treat       Date:  2011-12-16       Impact factor: 2.570

6.  Adherence to treatment: practice, education and research in Danish community pharmacy.

Authors:  Lotte S Haugbølle; Hanne Herborg
Journal:  Pharm Pract (Granada)       Date:  2009-03-15

Review 7.  Information about ADRs explored by pharmacovigilance approaches: a qualitative review of studies on antibiotics, SSRIs and NSAIDs.

Authors:  Lise Aagaard; Ebba Holme Hansen
Journal:  BMC Clin Pharmacol       Date:  2009-03-03

8.  Side effects of antineoplastic and immunomodulating medications reported by European consumers.

Authors:  Lise Aagaard; Ebba Holme Hansen
Journal:  J Res Pharm Pract       Date:  2013-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.